Ruxolitinib New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP02424CAS No. ：941678-49-5Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	941678-49-5	Cat. No.	BCP02424
Related Products	1092939-17-7（Ruxolitinib phosphate）
Name	Ruxolitinib
Synonyms	INCB 018424;INCB018424;INCB-018424; INC 424; INC424; INC-424; INCB18424; INCB 18424; INCB-18424;
SMILES	C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
Chemical Name
Formula	C17H18N6	M. Wt	306.36
Purity	98%	Storage	Store at 4-8°C
Description	Ruxolitinib is an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.